Elutia, Inc. - Class A Common Stock (ELUT)

Elutia, Inc. is a biotechnology company focused on developing and commercializing innovative therapies that aim to address unmet medical needs

The company specializes in regenerative medicine, particularly in the areas of tissue engineering and cell therapy, working to create advanced solutions that enhance the body's natural healing processes. Through rigorous research and development, Elutia is dedicated to transforming the treatment landscape for various conditions, improving patient outcomes, and contributing to the advancement of healthcare technologies.